Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06607692
Title Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined with the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). (LUPARPED)
Acronym LUPARPED
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundación de investigación HM
Indications
Therapies
Age Groups: child | adult
Covered Countries ESP


No variant requirements are available.